Get the Daily Brief
Latest Biotech News
AI and Computational Innovations Propel Biotech Research and Diagnostics
Advances in AI and computational technologies are reshaping biotech R&D and diagnostics. NIH researchers unveiled GeneAgent, an LLM-powered gene-set analysis tool that autonomously verifies...
Bayer, Bristol Myers, and Bain Drive Pharma Portfolio Reshaping and Financing
Bayer aims to revive growth through new drug launches as key products like Xarelto and Eylea plateau. Bristol Myers Squibb is realigning its pipeline by transferring five immunology assets,...
Sarepta's Duchenne gene therapy shipment reversal
The FDA has reversed its recent halt on Sarepta Therapeutics’ gene therapy Elevidys for ambulatory patients with Duchenne muscular dystrophy (DMD) following an investigation that concluded an...
Novo Nordisk cuts guidance amid leadership change
Novo Nordisk dramatically reduced its 2025 sales growth forecast to 8%-14% from a previous 13%-21%, citing ongoing challenges from lower sales of popular GLP-1 drugs due to knockoff competition....
Merck initiates $3B cost-cutting to refocus portfolio
Merck announced a sweeping initiative to save $3 billion annually by 2027, redirecting funds from mature products to support new launches and its experimental pipeline. The program involves...
Celcuity's breast cancer drug charts phase III success
Minneapolis biotech Celcuity reported positive phase III results for its breast cancer therapy gedatolisib, which demonstrated significant progression-free survival benefits in hormone...
GSK and Hengrui's $12.5B drug collaboration
GlaxoSmithKline inked a significant licensing deal with China’s Hengrui Pharmaceuticals for up to $12.5 billion, gaining rights to 12 drug assets including HRS-9821, a PDE3/4 inhibitor targeting...
GeneDx reports strong growth and raised revenue outlook
Genetic testing firm GeneDx posted a 49% increase in Q2 revenue driven by higher volumes of whole-exome and whole-genome sequencing tests, marking its fourth consecutive profitable quarter. The...
FDA expands approval for Apellis’ rare kidney disease drug
Apellis Pharmaceuticals won FDA approval for an expanded indication of its complement pathway drug pegcetacoplan (Empaveli), making it the second approved treatment for complement 3 glomerulopathy...
AI and computational advances boost biotech innovation
Recent advances in AI applications are reshaping biotech research and development. Researchers at NIH introduced GeneAgent, an AI agent that improves accuracy of gene-set analysis by reducing...
Bayer aims for growth with new product launches
Bayer outlined its strategy to return to growth leveraging new product launches as revenues from established drugs like Xarelto and Eylea plateau. The German pharma aims to replenish its portfolio...
FDA Clears Sarepta to Resume Duchenne Gene Therapy Shipments
The FDA reversed its earlier decision and authorized Sarepta Therapeutics to resume shipments of Elevidys, its gene therapy for ambulatory Duchenne muscular dystrophy (DMD) patients, after...
Merck Launches $3 Billion Cost-Cutting Plan to Bolster Pipeline
Merck & Co. announced a sweeping multiyear initiative aiming to cut $3 billion in annual costs by 2027, reallocating resources from mature assets to support newly launched and pipeline drugs. The...
GSK and Hengrui Pharma Ink Up to $12.5 Billion Deal for Respiratory and Oncology Assets
GSK partnered with Jiangsu Hengrui Pharmaceuticals in a licensing deal valued at up to $12.5 billion, centered on HRS-9821, a PDE3/4 inhibitor in phase I for chronic obstructive pulmonary disease...
GeneDx Reports Robust Growth with Strength in Genome and Exome Testing
Genetic diagnostics firm GeneDx posted a 49% year-over-year revenue increase in Q2 2025 to $102.7 million, fueled primarily by a 69% surge in whole-exome and whole-genome testing revenues, which...
Celcuity Breast Cancer Drug Surges on Positive Phase III Results
Minneapolis-based Celcuity’s experimental breast cancer therapy gedatolisib demonstrated significant efficacy in a phase III trial, achieving primary endpoints and substantially reducing...
Lab-Grown Beef Advances with Thicker, More Realistic Muscle Tissue
Researchers led by ETH Professor Ori Bar-Nur have successfully cultivated thicker, more anatomically realistic beef muscle tissue in laboratory settings. While official human consumption awaits...
AI-Powered Gene Set Analysis Tool Reduces Errors
Scientists at the U.S. National Library of Medicine developed GeneAgent, an artificial intelligence tool leveraging large language models (LLMs) with autonomous self-verification against...
Advances in Microbe-Based Therapeutics Controlled via Ingestible Capsules
Researchers have integrated engineered microbes with optoelectronic devices and smartphone interfaces to create the first fully controllable ingestible therapeutic platform. This system enables...
Novo Nordisk Cuts Sales Forecast Amid Obesity Drug Challenges and Names New CEO
Danish pharmaceutical leader Novo Nordisk slashed its 2025 sales growth forecast to 8%-14% from the prior 13%-21% range due to increasing competition from compounded semaglutide generics affecting...